Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults)
What the buyer wrote
NHS Arden and Greater East Midlands Commissioning Support Unit (AGCSU), on behalf of NHS England -Specialised Commissioning (referred to as the Authority), is inviting suitably qualified and experienced providers to respond to this Competitive Process for the provision of Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults).<br/><br/>As a result of this procurement exercise an agreement will be established with the successful bidder(s) for a period of three (3) years with the Commissioners having the option to extend for up to an additional two (2) year(s) (maximum contract duration 5 years).<br/><br/>The deadline for submissions is 12.00pm (noon) on Tuesday 24th June 2025…
Details
- What the buyer calls it
- Tumour Infiltrating Lymphocyte (TIL) Therapy hubs for Melanoma (Adults)
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- services
- Lots
- 7
- Where
- in London, in the East of England, in the South East, in the South West, in the East Midlands, in the West Midlands, in the North East, in Yorkshire and The Humber, in the North West
- Kind of work
- Mental health and wellbeing services
Who the buyer named
The buyer published a contact address on this notice.